THE RESPONSE OF VARIOUS TYPES OF BRONCHOGENIC CARCINOMA TO NITROGEN MUSTARD
Authors: B LEVINE, A S WEISBERGER
Journal: Annals of Internal Medicine (1955)

Article1 May 1955THE RESPONSE OF VARIOUS TYPES OF BRONCHOGENIC CARCINOMA TO NITROGEN MUSTARDBENNETT LEVINE, M.D., AUSTIN S. WEISBERGER, M.D.BENNETT LEVINE, M.D.Search for more papers by this author, AUSTIN S. WEISBERGER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-42-5-1089 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe beneficial effects of nitrogen mustard (HN2) in some cases of bronchogenic carcinoma is well known.1-15The number of patients receiving benefit from HN2therapy has varied from 18% to 74%.1-3, 5-11Most observers have made no correlation between the cell type of carcinoma and the degree of response to HN2therapy. Several investigators, however, have found that the undifferentiated or anaplastic type of bronchogenic carcinoma has responded best to HN2therapy.2, 5, 7, 8, 11, 15In the present study an attempt was made to correlate the response to HN2therapy with the type of bronchogenic carcinoma present. In...Bibliography1. RoswitKaplan BG: The role of nitrogen mustard as a systemic adjuvant to the radiation therapy of certain malignant diseases, Am. J. Roentgenol. 61: 622-636 (May) 1949. Google Scholar2. RoswitKaplan BG: Nitrogen mustard as an adjunct to radiation in the management of bronchiogenic cancer, Radiology 57: 384-394, 1951. CrossrefMedlineGoogle Scholar3. SkinnerCarr EFD: Palliative therapy of incurable intrathoracic malignancies, Am. Pract. and Digest Treat. 3: 900-910, 1952. MedlineGoogle Scholar4. La Due JS: Palliative treatment for advanced cancer of the lung, CA. 2: 85-86, 1952. Google Scholar5. ArielKanter IML: Nitrogen mustard therapy. A clinical study on the effects of methyl-bis (beta chloroethyl) amine hydrochloride on various types of neoplastic diseases, Am. J. Surg. 77: 509-521, 1949. CrossrefMedlineGoogle Scholar6. Ben-Asher S: Nitrogen mustard therapy, Am. J. M. Sc. 217: 162-168, 1949. CrossrefMedlineGoogle Scholar7. KentReh LEP: Treatment of bronchiogenic carcinoma with nitrogen mustard, Dis. of Chest 17: 190-201, 1950. CrossrefMedlineGoogle Scholar8. LynchWareGaensler JPPFEA: Nitrogen mustard in the treatment of inoperable bronchiogenic carcinoma, Surgery 27: 368-385, 1950. Google Scholar9. BoylandCleggKollerRhodenWarwick EJWPCEOH: Effect of chloroethylamines on tumors, with special reference to bronchiogenic carcinoma, Brit. J. Cancer 2: 17-25, 1948. CrossrefMedlineGoogle Scholar10. SkinnerCarrDenman EFDWE: Treatment of inoperable bronchiogenic carcinoma with methyl-bis (beta chloroethyl) amine hydrochloride, J. Thoracic Surg. 17: 428-438, 1948. CrossrefGoogle Scholar11. KarnofskyAbelmannCraverBurchenal DAWHLFJH: Use of nitrogen mustards in the palliative treatment of cancer, with particular reference to bronchiogenic carcinoma, Cancer 1: 634-656, 1948. CrossrefGoogle Scholar12. Videback A: On the use of nitrogen mustard as a therapeutic agent, Acta med. Scandinav. 135: 47-53, 1949. CrossrefMedlineGoogle Scholar13. Wauro NW: Experience with the use of nitrogen mustard at Hartford Hospital, Connecticut M. J. 12: 625-631, 1948. MedlineGoogle Scholar14. KarnofskyCraverRhoadsAbels DALFCPJC: An evaluation of methyl-bis (β-chloroethyl) amine and tris (β-chloroethyl) amine hydrochloride in the treatment of lymphomas, leukemia and allied diseases, Approaches to Tumor Chemotherapy, American Association for the Advancement of Science, Washington, 319-337, 1947. Google Scholar15. MayerRoswit EB: Newer palliative measures in the management of inoperable bronchiogenic carcinoma, Dis. of Chest 21: 491-512, 1952. CrossrefMedlineGoogle Scholar16. WeisbergerHeinleLevine ASRWB: The effect of l-cysteine on nitrogen mustard therapy, Am. J. M. Sc. 224: 201-211, 1952. CrossrefMedlineGoogle Scholar17. Ewing J: Neoplastic diseases, 1928, W. B. Saunders Co., Philadelphia. Google Scholar18. Barnard WG: The nature of the "oat-celled sarcoma" of the mediastinum, J. Path. and Bact. 29: 241-244, 1926. CrossrefGoogle Scholar19. KarsnerSaphir HTO: Small cell carcinoma of the lung, Am. J. Path. 6: 553-562, 1930. MedlineGoogle Scholar20. Maxwell J: Primary malignant intrathoracic tumors, J. Path. and Bact. 33: 233-249, 1930. CrossrefGoogle Scholar21. Koletsky S: Primary carcinoma of the lung, a clinical and pathological study of one hundred cases, Arch. Int. Med. 62: 636-651, 1938. CrossrefGoogle Scholar22. Karsner HT: Human pathology, 7th Ed., 1949, J. B. Lippincott Co., Philadelphia. Google Scholar23. Willis RA: Pathology of tumors, 1953, The C. V. Mosby Co., St. Louis. Google Scholar24. Storaasli JP: Personal communication. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Cleveland, Ohio*Received for publication October 15, 1954.From the Department of Medicine, University Hospitals, and the School of Medicine, Western Reserve University, Cleveland, Ohio.†Supported by the Price-McKinney Fund.‡Present address, Mount Sinai Hospital, Cleveland, Ohio. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byRefining the treatment of NSCLC according to histological and molecular subtypesMarcos históricos no estudo do cancro do pulmão**Trabalho realizado com base em artigos anteriormente publicados pelo autor332,337Marcos históricos no estudo do cancro do pulmãoTreatment of bronchogenic carcinomaCombination chemotherapy and radiation therapy in small cell carcinoma of the lungINTESTINAL ENTEROKINASECHEMOTHERAPY IN INOPERABLE BRONCHIAL CARCINOMALung Cancer: Perspectives and ProspectsPAUL P. CARBONE, M.D., JOHN K. FROST, M.D., ALVAN R. FEINSTEIN, M.D., GEORGE A. HIGGINS JR., M.D., OLEG S. SELAWRY, M.D.Bronchogenic carcinoma: Nitrogen mustard as a surgical adjuvant and factors influencing survival.University surgical adjuvant lung projectMechlorethamineChemotherapyAdvanced Lung Cancer Treated with CyclophosphamidePrognosis and Therapy of Tumors of the Lung with Pleural EffusionALKYLATING AGENTSOat cell lung cancerTRETAMINE COMPARED WITH NITROGEN MUSTARD IN THE PALLIATION OF INOPERABLE LUNG CANCERCARCINOMA OF THE LUNG — RESULTS OF TREATMENTTreating lung cancerClinical studies on anticancer agents 1 May 1955Volume 42, Issue 5Page: 1089-1096KeywordsHospital medicine Issue Published: 1 May 1955 PDF downloadLoading ...